Back to School: How biopharma can reboot drug development. Access exclusive analysis here

PPAR vigilance

PPAR vigilance

PPAR vigilance
Cardiovascular endpoints for selected compounds targeting the peroxisome proliferation activated receptor (PPAR) for diabetes, as described by

Read the full 216 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE